Mr Christopher Ogden, Consultant Urologist
Mr Christopher Ogden
Consultant Urologist
Mr Christopher Ogden MB BS MS FRCSEd FRCSEng FRCSUrol FEBU
Consultant Urologist
Recommendations for Mr Ogden
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
About Mr Christopher Ogden
GMC number: 2957661
Year qualified: 1984
Place of primary qualification: University of London
Mr Christopher Ogden is a renowned consultant uro-oncologist at The Harley Street Clinic and The Princess Grace Hospital, both part of HCA Healthcare UK. He is celebrated for his pioneering work in robotic surgery, having performed the first private robotic surgery in the UK. Since then, he has conducted thousands of robotically assisted procedures, establishing himself as a high-volume, experienced surgeon.
Mr Ogden's expertise extends to transperineal laser ablation (TPLA) of the prostate, a micro-invasive treatment offering excellent outcomes with minimal risk. He was the first consultant in the UK to perform this procedure and remains one of the few globally proficient in it. His work in TPLA was presented at the BAUS international congress in 2023, showcasing significant patient benefits and no complications.
In collaboration with Dr Jihad Kaouk from the Cleveland Clinic, Mr Ogden performed Europe’s first radical robotic perineal prostatectomy. This innovative approach has been developed in partnership with the NHS and reviewed positively at University College London Hospitals.
Mr Ogden was also among the first to use high intensity focused ultrasound (HIFU) for prostate cancer treatment. He has compared whole gland HIFU with robotic surgery and co-authored a paper on focal HIFU outcomes, published in the Journal of Urology.
A respected trainer in minimally invasive procedures, Mr Ogden continues to advance the field through research and education. He has presented numerous papers on TPLA and transperineal robot-assisted radical prostatectomy using the DaVinci Xi surgical system. His dedication to improving patient care and surgical outcomes makes him a leading figure in uro-oncology.
Areas of expertise
- Benign prostate hyperplasia
- Bladder cancer
- Bladder instillation
- Blood in urine (haematuria)
- Brachytherapy therapy
- Circumcision
- Conservative management
- Cryosurgery
- Cystoscopy
- Da vinci® prostatectomy
- Epididymal cysts
- Focal therapy (prostate cancer)
- High-intensity focused ultrasound (HIFU)
- Kidney disorders
- Kidney stones
- Laparoscopic surgery for kidney disorders
- Major pelvic surgery including neo-bladder construction
- Minimally invasive surgery
- MRI of prostate
- Nerve sparing prostatectomy
- Orchidectomy
- Prostate biopsy
- Prostate cancer
- Prostate robotic surgery
- Prostatectomy (radical)
- Prostatectomy (robotic)
- Prostatectomy (TURP)
- Prostatitis (prostate swelling)
- PSA testing
- Radiation therapy with either external bream
- Radical robotic prostatectomy
- Retzius-sparing radical prostatectomy
- Robotic surgery
- Testicular pain
- Transrectal ultrasound (TRUS)
- Transurethral resection of a bladder tumour (TURBT)
- Urethral and bladder neck sparing in prostatectomy
- Urinary incontinence
- Urinary tract infections (UTIS)
- Urological cancers
- Urological malignancy
- Urology robotic surgery
- Varicocele
- Vasectomy (male sterilization)
Professional memberships
Articles by Mr Christopher Ogden
Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer
An exploratory study of dose escalation versus standard focal high intensity focused ultrasound for treating non-metastatic prostate cancer
Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; results from the high intensity focused ultrasound evaluation and assessment of treatment (heat) registry
A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer
Mp30-11 predictors of poor functional outcomes after focal high intensity focussed ultrasound (HIFU)